Skip to content

Advertisement

  • Research article
  • Open Access

Zebrafish prdm12b acts independently of nkx6.1 repression to promote eng1b expression in the neural tube p1 domain

Neural Development201914:5

https://doi.org/10.1186/s13064-019-0129-x

©  The Author(s). 2019

  • Received: 11 January 2019
  • Accepted: 14 February 2019
  • Published:

Abstract

Background

Functioning of the adult nervous system depends on the establishment of neural circuits during embryogenesis. In vertebrates, neurons that make up motor circuits form in distinct domains along the dorsoventral axis of the neural tube. Each domain is characterized by a unique combination of transcription factors (TFs) that promote a specific fate, while repressing fates of adjacent domains. The prdm12 TF is required for the expression of eng1b and the generation of V1 interneurons in the p1 domain, but the details of its function remain unclear.

Methods

We used CRISPR/Cas9 to generate the first germline mutants for prdm12 and employed this resource, together with classical luciferase reporter assays and co-immunoprecipitation experiments, to study prdm12b function in zebrafish. We also generated germline mutants for bhlhe22 and nkx6.1 to examine how these TFs act with prdm12b to control p1 formation.

Results

We find that prdm12b mutants lack eng1b expression in the p1 domain and also possess an abnormal touch-evoked escape response. Using luciferase reporter assays, we demonstrate that Prdm12b acts as a transcriptional repressor. We also show that the Bhlhe22 TF binds via the Prdm12b zinc finger domain to form a complex. However, bhlhe22 mutants display normal eng1b expression in the p1 domain. While prdm12 has been proposed to promote p1 fates by repressing expression of the nkx6.1 TF, we do not observe an expansion of the nkx6.1 domain upon loss of prdm12b function, nor is eng1b expression restored upon simultaneous loss of prdm12b and nkx6.1.

Conclusions

We conclude that prdm12b germline mutations produce a phenotype that is indistinguishable from that of morpholino-mediated loss of prdm12 function. In terms of prdm12b function, our results indicate that Prdm12b acts as transcriptional repressor and interacts with both EHMT2/G9a and Bhlhe22. However, bhlhe22 function is not required for eng1b expression in vivo, perhaps indicating that other bhlh genes can compensate during embryogenesis. Lastly, we do not find evidence for nkx6.1 and prdm12b acting as a repressive pair in formation of the p1 domain – suggesting that prdm12b is not solely required to repress non-p1 fates, but is specifically needed to promote p1 fates.

Keywords

  • CRISPR
  • Dorsoventral patterning
  • Hindbrain
  • Spinal cord
  • Interneuron
  • Locomotion
  • Transcription

Background

Appropriate function of the adult nervous system requires the establishment of neural circuits during embryonic development. For such circuits to form properly, neurogenesis has to occur at the right time and place, neurons must migrate to the correct site and they must make appropriate connections. Disruptions to any step in this process result in improper neural circuit formation and such disruptions are thought to underlie many neurodevelopmental disorders – including schizophrenia and autism [1].

The embryonic vertebrate neural tube represents a well-studied system of neural circuit formation where various progenitor types form in distinct domains arrayed along the dorsoventral (DV) axis. These progenitor domains form in response to morphogen gradients – particularly dorsally derived Bone morphogenic protein (BMP) and ventrally derived Sonic hedgehog (Shh; reviewed in [2, 3]). In response to these morphogens, each progenitor domain acquires a unique gene expression profile that initially consists primarily of transcription factors (TFs). Strikingly, TFs unique to one progenitor domain frequently cross-repress the expression of TFs associated with adjacent domains, thereby establishing distinct boundaries that delineate individual progenitor domains along the DV axis. The graded morphogen signal, and the resulting distinct transcriptional programs, leads to the development of sensory neurons in the dorsal domains (pd1-pd5) and interneurons and motor neurons in the ventral domains (pd6-p0, p1, p2, pMN, p3) of the neural tube. Neurons from each of these domains then make connections to establish motor circuits that control the activity of limb and trunk musculature [4].

Many TFs that control establishment of progenitor domains along the DV axis belong to the homeodomain (HD) and basic Helix-Loop-Helix (bHLH) families. For instance, work in mouse and chick indicate that Shh activates genes such as Nkx6.1, Nkx6.2, Nkx2.2, and Olig2, while it represses Pax3, Pax6, Pax7, Dbx1, Dbx2 and Irx3 [5–13]. These TFs then repress each other’s expression to establish distinct progenitor domains. For instance, Irx3 and Olig2 are mutually repressive at the p2/pMN boundary [8, 14] such that loss of Olig2 leads to a ventral expansion of Irx3 expression, causing the pMN domain to give rise to V2 interneurons and astrocytes in place of motor neurons and oligodendrocytes [14]. More recently, members of the Prdm TF family have also been implicated in the formation of progenitor domains and the establishment of functional motor circuits (reviewed in [15]). The Prdm family consists of many members (Prdm1–16) that harbor an N-terminal PR domain, as well as a variable number of zinc fingers [16, 17], and that appear to preferentially act in complexes with bHLH TFs [15]. Hence, Prdm13 acts together with Ascl1 to promote formation of GABAergic neurons [18, 19], while Prdm8 interacts with the Bhlhe22 (a.k.a. Bhlhb5) TF to regulate axon outgrowth [20]. Of particular interest, Prdm12 is expressed in the developing CNS of mouse, frog, chick and zebrafish [21–23] – specifically in the p1 domain, which gives rise to V1 interneurons. Prdm12 deficiency in zebrafish and frog results in loss of eng1 expression from the p1 domain and animals lacking prdm12 function demonstrate a defective touch-evoked escape response [22, 23], suggesting that the V1 interneurons are absent. However, key aspects of Prdm12 function remain unclear. First, Prdm12 activity has only been assessed via overexpression and transient knock-down approaches – particularly antisense morpholino oligonucleotides (MOs) – that have recently come under scrutiny as prone to non-specific off-target effects. Furthermore, Prdm12 is suggested to act as a transcriptional repressor, but this is based on overexpression in fish and frog embryos [23, 24] and has not been stringently tested. Here, we generate and characterize the first germline prdm12 mutants using CRISPR/Cas9 to inactivate zebrafish prdm12b. prdm12b mutants display embryonic lethality and, in accordance with previous prdm12b MO analyses, we find that prdm12b mutants exhibit loss of eng1b expression in the p1 domain together with an abnormal touch-evoked escape response. We also employ luciferase reporter assays to reveal that Prdm12b acts as a bona fide repressor. This repression requires a conserved zinc finger domain that interacts with the Bhlhe22 TF, but, when we generate a bhlhe22 germline zebrafish mutant, it displays a normal p1 territory – indicating that bhlhe22 does not need to act with prdm12b for p1 progenitor formation in vivo. Lastly, while Nkx6.1 is known to repress p1 fates in other systems, we find that prdm12b and nkx6.1 does not form a reciprocally repressive TF pair in the zebrafish. Therefore, instead of the p1 domain taking on a p2 fate, a residual domain with unknown properties persists at the p1 position in prdm12b zebrafish mutants.

Methods

Zebrafish care

Wild type and mutant zebrafish were raised in the University of Massachusetts Medical School Aquatics Facility. All embryos were staged according to previously described morphological standards [25].

Generation of CRISPR/cas9 mutant zebrafish lines

We designed single guide RNAs (sgRNA) for the zebrafish prdm12b, bhlhe22 and nkx6.1 genes (Table 1) using the CHOPCHOP web tool [26]. Each sgRNA was assembled by annealing two single stranded oligonucleotides containing the T7 promoter and the target sequence (Additional file 1) followed by PCR amplification, purification and in vitro transcription using T7 RNA polymerase (Promega) as described previously [27]. A linearized plasmid encoding cas9 was used for in vitro transcription using the SP6 mMessage mMachine Kit (Ambion) according to the manufacturer’s instructions [28]. cas9 mRNA and sgRNA was co-injected into 1-cell stage zebrafish embryos at the following concentrations: 150 ng/μL sgRNA plus 200 ng/μL cas9 mRNA for prdm12b, 100 ng/μL sgRNA plus 200 ng/μL cas9 mRNA for bhlhe22 and 150 ng/μL sgRNA plus 200 ng/μL cas9 mRNA for nkx6.1. The next day, injected embryos were assayed for sgRNA activity by DNA extraction, PCR amplification, restriction digestion and DNA sequencing (Table 1). Detection of F0 founders was done by crossing sgRNA/cas9-injected animals with wildtype zebrafish and screening their offspring for mutagenic events using the diagnostic restriction enzymes listed in Table 1. Confirmed founders were crossed to wildtype animals to raise F1 carriers for each mutant.
Table 1

Characteristics of CRISPRs targeting prdm12b, bhlhe22 and nkx6.1

Target gene

Start Coordinate

Target sequence

Enzyme

Strand

Mutagenesis Ratea

Transmission Rateb

prdm12b

Chr5:66656496

GCTGGGGGAACACCTGTTCG

Taq1α

+

1/4

71/92 um318

43/79 um319

bhlhe22

Chr24:25069884

TTCACACACAAAGATCCGGT

BstYI

–

6/14

24/37 um320

nkx6.1

Chr21:17886500

AGTGGAGGATGCTGGTCCAG

AvaII

–

8/12

18/21 um321

aThe fraction of screened F0 animals that carried a mutagenic event

bThe fraction of screened F1 animals that were heterozygous for a mutagenic event

Antisense morpholino oligonucleotide injections

Antisense morpholino oligonucleotides (MOs) were obtained from Gene Tools LLC. MO injections were performed into the yolk of 1-cell stage embryos using 1-2 ng of solution containing dilutions of 3 mM morpholino stock, distilled water and phenyl red. An MO with the sequence 5′-GCAGGCAACACTGAACCCATGATGA-3′ was used to target the prdm12b translation start site. This MO was reported previously [22] and our analyses in this manuscript demonstrate that the effects of MO-mediated prdm12b knockdown are indistinguishable from the effects of prdm12b germ line mutations.

In situ RNA hybridization

Embryos were fixed in 4% paraformaldehyde (PFA) and stored in 100% methanol at − 20 °C. In situ RNA hybridization was performed as described [29] followed by a color reaction using NBT/BCIP in 10% polyvinyl alcohol. RNA probes for the genes eng1b, evx1, vsx2, pax3, nkx6.1, dbx1 and prdm12b were synthesized as previously described [27]. Embryos were dissected from the yolk and flat mounted in 80% glycerol for imaging on bridged coverslips or sectioned as described [30]. Images were captured using a Nikon Eclipse E600 microscope equipped with spot RT color camera (model 2.1.1). Images were imported into Adobe Photoshop and adjustments were made to contrast, levels, color matching settings and cropping only. All adjustments were made to the entire image.

Luciferase reporter assays

0.5 × 106 HEK293T cells were seeded in 6-wells plate and cultured in antibiotic free Dulbecco’s Modified Eagle Medium (DMEM; Gibco) supplemented with 10% fetal bovine serum (Hyloclone) overnight. Transient transfections were performed using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer’s instructions. For each transfection, 200 ng of the pGL4.31[luc2P/GAL4UAS/Hydro] reporter plasmid and 50 ng pRL-SV40 control plasmid was combined with varying concentrations of GAL4DBD expression plasmids (the fusion proteins were cloned into the pCS2 expression plasmid; exact concentrations are given in figure legends). Empty vector DNA was included to keep the total amount of DNA constant for all transfections. Luciferase activity was measured 24 h post transfection and firefly luciferase levels were normalized to renilla luciferase levels using the Dual Luciferase Reporter Assay System (Promega) following the manufacturer’s instructions in a Perkin Elmer Envision 2104 Multiplate reader. For Trichostatin A (TSA) treatment, transfected cells were exposed to either DMSO, 50 nM or 250 nM TSA for 12 h starting 24 h after transfection and then harvested for luciferase assays.

Co-immunoprecipitation and Western blotting

3 × 106 HEK293T were seeded in 10 cm dishes and transfected as above. Transfected cells were lysed in 4 mL of ice-cold co-IP buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.2 mM EDTA, 1 mM DTT, 0.5% Triton X100, 1X Complete Protease Inhibitor (Roche)) followed by incubation on ice for 30 min. Cell lysates were centrifuged at 2000 g for 10 min at 4 °C to eliminate cell debris. For immunoprecipitation, 8 μg of the mouse anti-Flag antibody (Sigma-Aldrich, F3165) was used in each sample and incubated at 4 °C overnight. 40 μL of Dynabeads was added in each sample and incubation was done for 4 h at 4 °C. Four washes of 1 mL co-IP buffer was used to eliminate non-specific binding. Lastly, immune complexes were eluted in 80 μL of 1X Laëmmli buffer (Biorad) containing 2.5% beta-mercaptoethanol. Samples were agitated at 95 °C for five minutes prior to Western blotting. Western Blotting was performed using rabbit HA antibody (Abcam, ab9110) as described previously [31].

Immunocytochemistry

Primary antibodies: mouse 3A10 (1:100; Developmental Studies Hybridoma Bank (DSHB) [32]), mouse F310 (1:100; DSHB [33]), mouse anti-Isl (39.4D5, 1:100; DSHB [34]), mouse 81.5C10 (Hb9; 1:400; DSHB [35]). Alexa Fluro secondary antibodies: 488, 568 goat anti-mouse (both at 1:200; Molecular probes). Embryos were fixed in 4% AB fix (4% paraformaldehyde, 8% sucrose, 1x PBS) overnight at 4 °C. Whole-mount fluorescent labeling was performed as described [36]. Images were captured on either Nikon Eclipse E600 (3A10, Isl1 and Hb9 staining) or a Zeiss LSM700 confocal microscope (F310 staining). Images were imported into Adobe Photoshop and adjustments were made to contrast, levels, color matching settings and cropping only. All adjustments were made to the entire image.

Behavioral analysis

Escape responses were elicited by a light tap to the head or tail of an embryo with a 3.22/0.16 g of force Von Frey filament. A high-speed digital camera (Fastec Imaging, San Diego, CA) mounted to a 35 mm lens (Nikon, Melville, NY), recorded each response at 1000 frames/s. Computer software generated in the Downes laboratory [37] quantified the head-tail angle for each frame, which was then plotted in Prism. The calculated escape response began in the frame preceding the first movement until movement was no longer observed.

Genotyping

CRISPR-generated mutant alleles of prdm12b, bhlhe22 and nkx6.1 were genotyped by Taq1α, BstYI or AvaII restriction digest, respectively, of PCR products amplified from genomic DNA using primers listed in Additional file 2. prdm12bsa9887 mutants were genotyped by sequencing of PCR products amplified from genomic DNA using primers listed in Additional file 2.

Total RNA from 24hpf WT and bhlhe22 zebrafish whole embryos was extracted with the RNeasy kit (Qiagen) following manufacturer’s instructions. Total RNA was then used in cDNA kit (ThermoFisher Scientific). Wildtype and bhlhe22 mutant transcripts were identified by sequencing of PCR products amplified from cDNA using primers listed in Additional file 2.

Results

Germline disruption of prdm12b blocks eng1b expression in the p1 domain

The prdm12 TF is known to be expressed in the developing CNS of mouse, chick, Xenopus and zebrafish [21–23] – particularly in sensory ganglia and in the p1 domain of the neural tube. The p1 domain gives rise to eng1b-expressing V1 interneurons that regulate motor circuits in several vertebrate species [38–40]. Disruption of prdm12 function using antisense morpholino oligonucleotides (MOs) leads to the loss of eng1b expression in the p1 domain, but not in other eng1b expressing tissues – such as the midbrain-hindbrain boundary (MHB) and the somites – in zebrafish and Xenopus [15, 23], but there have been no germline mutations for prdm12 produced in any organism. Importantly, recent work has demonstrated several cases where apparently specific MO-derived phenotypes do not match the phenotypes of germ line mutants for the same gene [41]. The underlying causes of such discrepancies are varied, but include off-target effects, as well as compensatory changes in the expression of genes with similar functions to the targeted gene [42]. Hence, it is essential to confirm MO-derived phenotypes by comparisons to the phenotypes of germline mutant animals. To this end, we used the CRISPR/Cas9 genome editing system [43, 44] to generate prdm12b germline mutant zebrafish. We tested five sgRNAs targeting the first exon of the prdm12b gene and identified one that efficiently disrupts a diagnostic Taqα1 site at position 129 of prdm12b exon 1 in 24hpf zebrafish embryos (Fig. 1A, B). Injected embryos were raised to adulthood and screened to identify founders that carry mutations in the prdm12b gene (Fig. 1c). In this manner, we identified one mutant F0 founder out of four tested (Table 1). Since zebrafish F0 founders are usually mosaic, this founder was crossed to wildtype fish and the resulting F1 generation raised to adulthood (Fig. 1d). Genotyping revealed that the F0 founder transmitted mutations to 77% (114/171) of its F1 offspring (Table 1). Subsequent sequencing of genomic DNA from individual F1 fish identified two different alleles (prdm12bum318 and prdm12bum319; Fig. 1e, f; Additional file 3). In both alleles, the mutant sequence leads to a frameshift and premature termination of translation upstream of the conserved PR domain and the zinc finger domains. In addition, while we were in the process of generating prdm12b mutants, a mutant prdm12b allele became available from the zebrafish information resource center (ZIRC) as a product of the zebrafish mutation project (ZMP). This mutant allele (prdm12bsa9887) is ENU-derived and carries a T > C change in an essential splice site at the beginning of intron 2, within the PR domain and upstream of the zinc finger domains (Additional file 4A). We obtained this line from ZIRC and confirmed the presence of the expected mutation by sequencing (Additional file 4B, C).
Fig. 1
Fig. 1

Generation of germ line prdm12b mutants. a. Schematic showing genomic sequence of prdm12b. Exons are indicated as boxes and black lines represent introns. The PR domain and three zinc fingers (ZnF) are highlighted in dark red and blue, respectively. The CRISPR target sequence is shown in red with the Taq α1 restriction site bracketed and the black arrow indicating the Taq α1 cut site. b. Identification of functional guide RNAs. sgRNA and cas9 mRNA was injected into 1-cell stage embryos. Injected embryos were raised to 24hpf and Taq α1 digestion of PCR amplicons from pools of embryos was used to identify CRISPR-induced mutations (black arrow). c. Identification of individual F0 founders. sgRNA/cas9 injected embryos were raised to adulthood and crossed to wildtype fish. Taq α1 digests of PCR amplicons from pools of embryos was used to identify F0 mosaic founders (black arrow). d. Identification of F1 animals. Adult F0 mosaic founders were out-crossed to wildtype fish and the F1 offspring raised to adulthood. Taq α1 digests of PCR amplicons from individual fin clip genomic DNA was used to identify heterozygous F1 animals. e. Sequencing of F1 genomic DNA revealed the transmission of two different mutant alleles (um318, um319). um318 carries a 42 base pair deletion (black dashes) and a 16 base pair insertion (blue), while um319 carries a 17 base pair deletion (black dashes). The CRISPR target sequence is shown in red. f. Predicted amino acid sequence of mutant alleles. The um318 peptide shares its first 41 amino acids, and the um319 peptide its first 43 amino acids, with wildtype Prdm12b. The two mutant peptides then utilize a different reading frame that terminates at a premature stop codon N-terminal to the conserved PR domain. Inj = sgRNA/Cas9-injected embryos, uninj = uninjected control embryos

Since the effects of MOs wear off as development progresses (largely due to MO degradation) they are not a reliable tool to assess genetic effects on embryo viability. However, having generated prdm12b germ line mutants, we were able to examine the effect of prdm12b on viability by crossing heterozygous carriers and genotyping the resulting offspring at different stages of embryogenesis. prdm12b mRNA does not appear to be maternally deposited (Fig. 2a, b) and is not detected until the end of gastrulation [15], suggesting a relatively late role in development. Accordingly, we observe the expected ~ 25% homozygous prdm12b mutants (26/139 for um318 and 29/116 for um319) at 4dpf (Fig. 2c), but by 15dpf only ~ 13% of embryos are homozygous mutant (22/172 for um319) and by 21dpf we no longer detect any homozygous mutants (0/129 for um319). We also do not observe homozygous mutants when genotyping adult offspring (2 months of age; 0/92 for um318 and 0/145 for um319) from these crosses. Since prdm12b mutants start dying between 4dpf and 15dpf, we monitored developing embryos more closely during this time interval and noticed that a fraction of embryos grew at a slower rate (Fig. 2d, e). When the smaller embryos were genotyped, 82% (18/22) turned out to represent homozygous prdm12b mutants. This slower rate of growth suggests that the mutants may be unable to feed properly (perhaps due to the motility defects described below). However, when fed brine shrimp, even the mutant embryos show evidence of food in their digestive tract (orange/yellow color in Fig. 2d, e). Hence, the mutants are capable of feeding, although we cannot exclude the possibility that they do so sub-optimally.
Fig. 2
Fig. 2

prdm12b germ line mutants lack eng1b expression in the p1 domain. a, b. prdm12b is not maternally deposited. In situ hybridization detects prdm12b expression at 24hpf (b), but not at 2.5hpf (a), in wildtype embryos. c. Bar chart depicting the frequency of each genotype at various time points in broods from crosses of prdm12b heterozygous animals. Error bars indicate ±S. E. (n = 3). dpf = days post fertilization, mo = months. d, e. Morphology of 15dpf prdm12b+/+ (d) and prdm12bum319/um319 (e) fish. f-s. eng1b expression in 24hpf embryos from crosses of prdm12b+/um318 heterozygotes (f-k), or prdm12b+/um319 heterozygotes (l-s). Numbers in each panel indicate the fraction of animals with the specified phenotype. t, u. evx1 expression in 24hpf embryos from a cross of prdm12b+/um319 heterozygotes. v, w. vsx2 expression in 24hpf embryos from a cross of prdm12b+/um319 heterozygotes. Embryos are shown in dorsal (f-h, l-n, t-y) or lateral (i-k, o-q) view with anterior to the left, or in cross section (r, s) with dorsal to the top. Brackets indicate r4, arrows mark V1 interneurons and arrowheads mark somites. MHB = midbrain–hindbrain boundary, HB = hindbrain and SC = spinal cord

Since loss of eng1b expression in the p1 domain is the key feature of the zebrafish prdm12b morphant phenotype, we next assayed eng1b expression in all three prdm12b mutant alleles by in situ hybridization at 24hpf. For both CRISP/Cas9-generated alleles, ~ 25% of embryos from crosses of heterozygous carriers lack eng1b expression in hindbrain and spinal cord (Fig. 2f-q). In the affected embryos, eng1b expression is lost from the p1 domain, but persists at the MHB and in the somites (whole mount in Fig. 2h, k, n, q and section in Fig. 2s). Genotyping revealed that all embryos lacking eng1b expression in the p1 domain represent homozygous prdm12b mutants (45/45 for prdm12bum318 and 13/13 for prdm12bum319). Similarly, eng1b expression is lost in both hindbrain and spinal cord in 27% of embryos from a cross of prdm12bsa9887/+ heterozygous fish, while the remaining embryos show unaffected eng1b expression (Additional file 4D-G). We conclude that germ line mutants for prdm12b display the same loss of eng1b expression as previously reported for prdm12b morphants.

Prdm12b mutant animals display an abnormal escape response

V1 inhibitory interneurons are responsible for the modulation of motor circuits in many species, including zebrafish, Xenopus and mouse ([25, 32], reviewed in [45]). Accordingly, we previously demonstrated that prdm12b morphants display abnormal movements in response to touch [15]. The touch-evoked escape response is a classical method of assessing functionality of motor output in aquatic species [46] and it has been applied to zebrafish [47, 48]. In this test, a touch stimulus causes the fish to undergo a large amplitude body bend (C bend), which reorients the animal away from the stimulus. The initial large amplitude body bend is followed by lower amplitude counter bends, allowing the fish to propel itself away. Strikingly, the escape response of prdm12b morphants is exaggerated, such that morphants perform not just one, but several repetitive C-bends and, compared to a wild type response – which lasts ~ 100 ms – the response of prdm12b morphants is prolonged and may continue for several hundred milliseconds [15]. To determine if this defect is observed also in germline mutants, we assessed the escape response of 4dpf old prdm12b mutant fish to a head tap, followed by genotyping. We find that all prdm12b mutants (9/9 for um318 and 8/8 for um319), respond by carrying out repetitive C-bends (up to seven C-bends) for extended periods of time (Fig. 3a, b; Additional files 5, 6 and 7). We extended this analysis to also score the response of prdm12bum319 homozygous mutant animals when tapped on the tail. We observed no differences between responses to head versus tail stimulation – in all 11 cases were the responses exaggerated to both stimuli (Fig. 3c, d; Additional files 5, 8, 9). The touch-evoked escape response is mediated via reticulospinal neurons – most notably the Mauthner cells, but also MiD2 and MiD3 cells – and our results therefore indicate that this pathway is abnormal in prdm12b mutants. Notably, there is no known circuit connecting V1 interneurons to the reticulospinal cells, suggesting that the abnormal escape response observed in prdm12b mutants may be independent of the loss of V1 interneurons. Indeed, the behavior of the mutants is consistent with enhanced or excessive activity of this pathway, perhaps due to impaired synapse function or circuit regulation. Accordingly, we do not detect structural defects in either the morphology of Mauthner cells (Fig. 3e), or the structure of trunk/tail musculature (Fig. 3f). We conclude that prdm12b germ line mutant animals display a defective escape behavior that is qualitatively and quantitatively indistinguishable from that of prdm12b morphants.
Fig. 3
Fig. 3

prdm12b mutant fish display an abnormal touch evoked response. a-d. Representative kinematic traces for 10 wildtype (a) and 11 prdm12b mutant (b) fish stimulated with a head touch, as well as for 11 prdm12b mutants first assayed with a head touch (c) and subsequently with a tail touch (d). Zero degrees on the y-axis indicate a straight body while positive and negative angles represent body bends in opposite directions. All fish were at 4dpf. e. Anti-3A10 labeling of Mauthner neurons in a cross of prdm12b+/um318 heterozygotes (n = 117). f. Anti-F310 labeling of somites in a cross of prdm12b+/um398 heterozygotes (n = 16)

Prdm12b acts as a repressor in vitro

The fact that prdm12b belongs to a family of transcription factors, together with the finding that loss of prdm12b function abolishes eng1b expression, suggests that this factor may function as a transcriptional activator. Accordingly, transfection of prdm12 into P19 cells upregulates p27 mRNA and protein levels [49]. However, recent reports instead suggest that prdm12 acts as a repressor [23], but this conclusion was based on overexpression experiments in vivo and has not been tested directly. To more directly determine whether prdm12b acts as an activator or repressor, we made use of classical reporter assays. While prdm12b possesses three putative zinc-fingers (ZnFs), it is not clear if these are sufficient for DNA binding and there is no well-defined genomic motif for Prdm12b binding. We therefore fused the well-characterized DNA binding domain (DBD) from the GAL4 transcription factor in-frame to the N-terminus of zebrafish Prdm12b (Fig. 4a; Additional file 10). Transcriptional activity was measured using the pGL4.31 reporter vector that contains multiple GAL4 binding sites (upstream activation sequence; UAS) in front of the firefly luciferase gene. Co-transfection of the reporter plasmid together with the GAL4-DBD alone led to a modest increase in Luciferase activity (Fig. 4b). Strikingly, when the GAL4DBD-Prdm12b fusion protein was instead co-transfected with the reporter plasmid, a dose-dependent reduction in Luciferase activity was observed (Fig. 4b), indicating that the Prdm12b protein functions as a repressor.
Fig. 4
Fig. 4

The zinc finger domain is necessary for Prdm12b-mediated repression. a. Diagram of GAL4DBD-Prdm12b constructs. FL = full-length, PR = PR domain, ZnF = zinc finger domain. b-e. Reporter assays in HEK293 cells testing activity of GAL4DBD-Prdm12b constructs. For each experiment, the pRL-SV40 renilla-luciferase control plasmid and the pGL4.31 UAS:Firefly-luciferase reporter plasmid were co-transfected with the indicated GAL4DBD-Prdm12b construct or with a plasmid containing the GAL4DBD alone. Each construct was tested in triplicate and luciferase activity is expressed as mean fold induction ± SE over pGL4.31 reporter alone. Transfection efficiency was corrected by normalizing to renilla luciferase activity

Prdm12b contains two types of conserved domains – the PR domain and the zinc fingers. The PR domain is related to SET domains that function as histone lysine methyl transferases (HMTs). Most PR domain proteins lack the H/RxxNHxC motif that is essential for HMT activity [50]; however, Prdm2, Prmd3, Prdm6, Prdm8, Prdm9 and Prdm13 were recently shown to exhibit intrinsic methyltransferase activity [51–55]. Accordingly, the PR domain of Prdm12b has been postulated to act as a H3K9 methyltransferase – to deposit methyl groups onto lysine 9 of histone 3 –thereby repressing gene expression [24]. A recent study of Prdm9 demonstrated that cysteine 321 (Cys321) is highly conserved among Prdm family members that have intrinsic histone methyl transferase activity and that substituting Cys321 with a proline decreases Prdm9 activity ~ 1000 fold [56]. Our sequence comparison of Prdm1, 9, 10 and 12b revealed that Prdm12b carries a cysteine residue (Cys164) at the analogous position to Cys321 in Prdm9, while Prdm1 and Prdm10 (that lack methyltransferase activity) contain a proline at this position. To determine the functional contribution of Cys164, we tested the activity of several substitution mutants using the luciferase assay, but neither a cysteine - > proline, nor a cysteine - > alanine, substitution at position 164 affected the repressive activity of Prdm12b (Fig. 4c). Deletion of the entire PR domain proved to be uninformative as this protein was unstable in HEK293 cells (Additional file 10). Previous work also demonstrated that some Prdm proteins act as repressors by recruiting histone deacetylases (HDACs) via the PR domain [57–59], but we find that Trichostatin A (TSA; a HDAC inhibitor) does not affect the repressive activity of Prdm12b (Fig. 4d). Lastly, we deleted the conserved zinc fingers in Prdm12b in order to determine if they might be required for its repressive function. Strikingly, deletion of the ZnFs completely abolished the repressive activity of Prdm12b and instead appears to produce a protein with slight activator activity (Fig. 4e). Taken together, our results indicate that Prdm12b functions as a repressor and that this activity requires intact zinc finger domains, at least in the context of a GAL4DBD fusion protein.

Prdm12b interacts with the Bhlhe22 transcription factor and the EHMT2 methyltransferase

As discussed, it is unclear if Prdm12b binds DNA directly and it may instead be recruited to genomic binding sites by forming complexes with a DNA-binding factor. Since prdm12b is expressed only in the p1 domain, we focused our search for DNA-binding Prdm12b-interactors to ones that are co-expressed with prdm12b in the p1 domain. Based on this criterion, the Bhlhe22 transcription factor (also known as Bhlhb5) represents a potential binding partner for Prdm12b. In particular, bhlhe22 is expressed in the pdl6, p1, p2 and p3 domains and has been implicated in the specification of V1 and V2 interneurons [60]. Furthermore, Bhlhe22 has been shown to form complexes with Prdm8, suggesting that it may act broadly as a partner for Prdm proteins [20]. Using co-immunoprecipitation, we confirmed the interaction between Bhlhe22 and Prdm8 (Fig. 5a, lane 9) and further demonstrated robust binding between Bhlhe22 and Prdm12b (Fig. 5a, lane 6). More detailed analyses using Prdm12b deletion constructs indicated that the ZnF domain – that we already identified as necessary for Prdm12b-mediated repression (see Fig. 4d) – is required for Bhlhe22 binding (Fig. 5a, lane 7). In contrast, the PR domain does not appear to be absolutely required for the Prdm12b-Bhlhe22 interaction (Fig. 5a, lane 8).
Fig. 5
Fig. 5

Prdm12b interacts with Bhlhe22 and EHMT2/G9a. a, b. Co-immunoprecipitation experiments assaying interactions between Prdm12b and Bhlhe22 or EHMT2/G9a. The indicated constructs were co-transfected into HEK293T cells followed by immunoprecipitation with anti-Flag and Western blotting with anti-HA. Arrows at right indicate the expected sizes of each protein. Additional file: 10B demonstrates that Flag-G9a and Flag-Bhlhe22 are stable upon transfection into HEK293 cells

Moreover, since Prdm12b appears to lack intrinsic methyltransferase activity, it must function by recruiting factors to mediate its repressive effects. Accordingly, Prdm family members recruit various transcriptional repressors ([61–64] and reviewed in [16]). In particular, Prdm1, 5 and 6, as well as Prdm12, have been shown to bind EHMT2/G9a – a H3K9 methyltransferase [57, 59, 65, 66]. In the case of Prdm12, binding to EHMT2/G9a is reportedly mediated by the ZnF domains [49]. Since this is the same domain that we find to be required for binding to Bhlhe22, we examined this in further detail. We confirmed that Prdm12b interacts with EHMT2/G9a (Fig. 5b, lane 2), but find that neither the ZnF, nor the PR domain, is required for this binding (Fig. 5b, lanes 5 and 8).

We conclude that Prdm12b binds to both Bhlhe22 and EHMT2/G9a. Additionally, the Prdm12b ZnF domain – that is essential for Prdm12b-mediated repression – is required for binding to Bhlhe22, but not to EHMT2.

bhlhe22 is not required for eng1b expression in the zebrafish p1 domain

Previous work reported that siRNA-mediated knock-down of bhlhe22 in the chick spinal cord leads to a reduction in eng1 expression in the p1 domain [60], akin to the effect we observe in prdm12b mutants. The similarity of the bhlhe22 and prdm12b loss-of-function phenotypes, taken together with our finding that these two proteins form complexes, suggests that bhlhe22 and prdm12b may cooperate to control eng1b expression. To test this possibility, we generated germline mutants for zebrafish bhlhe22 using the CRISPR/cas9 system. Specifically, a sgRNA targeting the 5′ end of the bhlhe22 coding sequence (that is contained on a single exon) was used to generate six founders carrying mutations in the bhlhe22 gene (Table 1; Additional file 11A-D). One founder was characterized further and found to transmit a small deletion that introduces a frameshift, which is predicted to cause premature termination of Bhlhe22 protein synthesis upstream of the bHLH domain (Additional file 3B, Additional file 11E). We find that animals homozygous for this mutant allele (bhlhe22um320) are viable to adulthood (Fig. 6a). As expected, sequencing of bhlhe22 transcripts from such homozygous animals detected only the mutant sequence confirming presence of the mutant allele (Fig. 6b). To test if bhlhe22 might function with prdm12b in p1 formation, we examined eng1b expression in bhlhe22um320 animals by in situ hybridization. We find that expression of eng1b is unaffected in homozygous bhlhe22 mutants (Fig. 6c). Since siRNA-mediated knock-down of bhlhe22 reportedly disrupts gene expression in p0-p2 of chick embryos [60], we also examined expression of vsx2 in the p2 domain (Fig. 6d) and evx1 in the p0 domain (Fig. 6e), but do not observe any disruptions. We conclude that, in contrast to the situation in chick, zebrafish bhlhe22 is not required for p1 domain formation.
Fig. 6
Fig. 6

Analysis of bhlhe22 mutant zebrafish. a. Chart depicting the frequency of each genotype at various timepoints in broods from crosses of bhlhe22+/um320 heterozygous fish. mo = month, y/o = year old. b. Sequencing traces of transcripts from wild type versus bhlhe22um320/um320 animals showing the expected 5 bp deletion. c-e. Expression of eng1b (c), evx1 (d) and vsx2 (e) in 24hpf wildtype and bhlhe22um320/um320 mutant embryos

prdm12b does not maintain the p1 domain by repressing nkx6.1

Repressive interactions are common during formation of the neural tube, whereby mutually repressive pairs of TFs are involved in the establishment of individual progenitor domains (reviewed in [2, 15]). Since prdm12b appears to act as a repressor, it is plausible that it forms a repressive pair with nkx6.1 to establish the p1 domain and permit eng1b expression. Accordingly, nkx6.1 mutant mice display a ventral expansion of the p1 domain at the expense of the p2, pMN and p3 domains [67]. Furthermore, dorsal expansion of nkx6.1 has been reported in prdm12 MO-injected fish and frog embryos [22, 23] and overexpression of prdm12 inhibits nkx6.1 expression in frog embryos. To test this model further, we generated nkx6.1 mutant zebrafish by targeting a sgRNA to the 5′ end of exon 1. This produced eight founders carrying mutations in the nkx6.1 gene (Table 1; Additional file 3C; Additional file 12). Five of these were characterized further and found to transmit two different mutant alleles. The nkx6.1um321 allele contains a 23 bp deletion while the nkx6.1um322 allele carries a 1 bp insertion (as well as three single base pair substitutions). In both alleles, this leads to frameshifts that terminate at a premature stop codon upstream of the HOX domain. Accordingly, immunostaining with an anti-Nkx6.1 antibody revealed loss of Nkx6.1 protein in homozygous nkx6.1um321/ um321 mutants (Fig. 7a). Similar to the situation with prdm12b mutants, we find that homozygous nkx6.1um321 mutant animals are observed at the expected ratio during early development, but we detect only a few homozygous nkx6.1um321 animals at adulthood (Fig. 7b). While nkx6.1 mutant mice display a profound loss of motor neurons [67], nkx6.1 MO-injected zebrafish show defective formation in only a subset of motor neurons and only at later stages of development [68, 69]. In general agreement with these MO-based zebrafish studies, we do not detect overt changes in expression of the hb9 motor neuron marker in nkx6.1 mutant zebrafish (Fig. 7c), but we do observe subtle defects in the formation of branchiomotor neurons in the hindbrain (Fig. 7d).
Fig. 7
Fig. 7

prdm12b does not maintain the p1 domain by repressing nkx6.1. a. Anti-Nkx6.1 immunostaining of nkx6.1um321/um321 mutant (left) and wildtype (right) embryos at 30hpf. b. Chart indicating the frequency of each genotype at various time points in broods from crosses of nkx6.1+/um321 heterozygous mutants. c. Hb9 immunostaining in wildtype (left) versus a cross of nkx6.1+/um321 heterozygous embryos (right) at 33hpf. d. Islet-1/2 immunostaining of 50hpf embryos from a cross of nkx6.1+/um321 heterozygotes. e. Expression of eng1b in 24hpf embryos from a cross of nkx6.1+/um321 heterozygotes. f. Expression of eng1b in 24hpf uninjected wildtype embryos (left panels), 24hpf prdm12b MO-injected wildtype embryos (middle panels) and 24hpf prdm12b MO-injected embryos from a cross of nkx6.1+/um321 heterozygotes (right panels). g. Expression of prdm12b in a representative wildtype embryo (left panel) and a representative embryo from a cross of nkx6.1+/um321 heterozygotes (middle panel) at 24hpf. Right panel shows quantification of the size of the prdm12b expression domain in 11 wildtype embryos and 20 embryos from a cross of nkx6.1+/um321 heterozygotes. Numbers in panels indicate the fraction of embryos displaying the phenotype shown

We next used the nkx6.1 mutant fish to test if nkx6.1 and prdm12b act as a repressive pair to establish the p1 domain and enable eng1b expression. However, we do not find evidence for expansion of the eng1b (Fig. 7e) or prdm12b (Fig. 7g) expression domains in nkx6.1 mutants. In accordance with previous reports, we observe a slight expansion of the nkx6.1 domain in prdm12b loss of function animals, but this effect falls below the level of statistical significance (Additional file 12G). Furthermore, if nkx6.1 and prdm12b act as a repressive pair, nkx6.1 would expand into the p1 domain in prdm12b mutant animals, thereby expanding the p2 domain at the expense of the p1 domain and leading to loss of eng1b expression. Therefore, we would expect eng1b transcripts to be present in the p1 domain of animals lacking both nkx6.1 and prdm12b function. To test this, we microinjected the prdm12b MO (that we know phenocopies the prdm12b germ line mutant; see Figs. 1, 2 and 3 [22]) into embryos from a cross of heterozygous nkx6.1um321 carriers. We find that eng1b expression is absent in all MO-injected embryos, regardless of nkx6.1 status (Fig. 7f), indicating that loss of eng1b expression is not the result of nkx6.1-mediated expansion of the p2 domain. Lastly, if the loss of eng1b expression in prdm12b mutants is due to expansion of adjacent domains, we would expect the p1 domain to be absent in prdm12b loss of function animals. Using five different combinations of domain-specific genes as markers, we find that the p1 domain is significantly smaller, but still present, in the absence of prdm12b function (Fig. 8a-o). We conclude that prdm12b is required for establishing an appropriately sized p1 domain, not for preventing nkx6.1-mediated dorsal expansion of adjacent domains.
Fig. 8
Fig. 8

prdm12b controls the size of the p1 domain. Expression of pax3/nkx6.1 (a, b), dbx1/nkx6.1 (d, e), pax3/vsx2 (g, h), dbx1/vsx2 (j, k) and evx1/nkx6.1 (m, n) in 24hpf wildtype (a, d, g, j, m) or prdm12b MO-injected (b, e, h, k, n) embryos. Panels show cross sections through the spinal cord with dorsal to the top. c, f, i, l, o show quantification of the size (along the dorsoventral axis) of the p0/p1 domain (c, i) or the p1 domain (f, l, o) relative to the neural tube. At least 10 representative sections were used for each gene pair

Discussion

We report the first germline mutants disrupting function of the prdm12 TF. In particular, we find that three distinct zebrafish prdm12b mutant alleles produce an identical phenotype. We use these lines to extend previous characterization of prdm12 loss of function animals to demonstrate that prdm12b is essential for embryonic development, specifically for formation of the neural circuit controlling a classical escape response. Using in vitro approaches, we further demonstrate that Prdm12b functions as a bona fide transcriptional repressor – most likely by recruiting EHMT2/G9a. Although Prdm12b binds via its essential zinc-finger domain to the Bhlhe22 TF, generating and analyzing a bhlhe22 germline zebrafish mutant revealed no effects on eng1 expression in the p1 domain – indicating that prdm12b and bhlhe22 do not need to act together for p1 formation in vivo. Lastly, it has been suggested that prdm12b and nkx6.1 form a cross-repressive TF pair essential for the establishment of p1 domain fates. We tested this hypothesis by generating a nkx6.1 germline zebrafish mutant and analyzing it along with our prdm12b mutant, but do not find support for such a cross-repressive arrangement. In fact, instead of the p1 domain taking on a p2 fate in prdm12b mutants, a domain persists at the p1 position, but it does not express genes indicative of a specific progenitor class.

prdm12b germ line mutants recapitulate the phenotype observed using antisense-based approaches

Prdm12 function has been addressed previously, but only by transient loss of function approaches. In particular, antisense morpholino oligos (MOs) were first used in zebrafish [22] and subsequently in frog [23, 24] to disrupt prdm12 function. The resulting animals lack expression of eng1 in the p1 domain of the neural tube, but gene expression appears relatively normal in adjacent domains. eng1-expressing progenitors in the p1 domain are known to give rise to V1 interneurons that act in motor circuits (reviewed in [45]). Accordingly, fish and frogs lacking prdm12 function display abnormal escape responses [22, 23], but the nature of this effect (excessive C-bends) suggests a defect in a reticulospinal cell-controlled circuit that is likely independent of the loss of V1 interneurons. Importantly, recent work has highlighted significant concerns with MO-based approaches. In particular, there are many instances where germ line mutations do not confirm previous reported MO-based phenotypes [41]. While some of these cases may be explained by underappreciated compensatory mechanisms [70], there are striking examples of MO phenotypes that turn out to be due to non-specific or off-target effects [27]. Against this background, it is essential to determine the phenotype of prdm12 germline mutants. To address this, we used CRISPR/Cas9 to generate two lines carrying frameshift mutations in the zebrafish prdm12b gene and also obtained an ENU-induced splice-site mutation from the zebrafish resource center. All three lines display a phenotype that is in good agreement with MO-derived data. In particular, germline mutants lack eng1b expression and display escape response defects indistinguishable from those in MO injected embryos. Hence, our findings indicate that, in this case, the various MOs act specifically. Since there is currently no available prdm12 knockout line in mouse, it remains possible that there will be species-specific differences in prdm12 function, as was recently observed when comparing MO-injected, zebrafish germ line mutants and mouse germ line mutants of the PG1 hox genes [71].

prdm12b is a bona fide transcriptional repressor

The Prdm12 TF has been suggested to act as a repressor based on overexpression studies in vivo and in dissected frog embryos [23, 24], but as an activator based on transfection experiments in P19 cells [49]. To address this discrepancy, we made use of classical reporter assays and find that zebrafish Prdm12b efficiently represses expression from a luciferase reporter gene. Other members of the Prdm family have been reported to act as repressors, but appear to use distinct mechanisms to do so. For instance, several Prdm TFs recruit histone deacetylases (HDACs) to repress transcription, but we find that an HDAC inhibitor does not affect the repressive properties of Prdm12b, indicating that it functions independently of HDACs. Overexpression of Prdm12 also promotes the deposition of repressive methyl marks on H3K9 [23, 24, 49]. Accordingly, the PR domain of some Prdm proteins exhibits methyltransferase activity and this domain is required for Prdm12 function in Xenopus [23]. However, we find that mutating a key conserved PR domain residue does not affect the repressive activity of prdm12b. Accordingly, in vitro analyses using core histone substrates failed to detect intrinsic methyltransferase activity for Prdm12 [49]. Notably, murine Prdm12 binds EHMT2/G9a (an H3K9 methyltransferase; [49]) and EHMT2/G9a is required for Prdm12 function in Xenopus [23], suggesting that Prdm12 may act as a repressor by recruiting EHMT2/G9a. We show that zebrafish Prdm12b also binds EHMT2/G9a, but in contrast to the situation in the mouse, the Prdm12b zinc finger domains are not required for this interaction.

In spite of the presence of several zinc finger domains, many Prdm proteins require interactions with other TFs for targeting to genomic binding sites. In particular, several Prdm proteins form complexes with bHLH TFs [15]. For instance, Bhlhe22 is known to interact with Prdm TFs [20] and is required for expression of eng1 in the chick neural tube [60], making it a candidate interaction partner for Prdm12b. Indeed, we show by co-immunoprecipitation that Prdm12b and Bhlhe22 can form a complex. Furthermore, this interaction requires the Prdm12b zinc finger domain that we find is required for Prdm12b repressor activity. To test the role for bhlhe22 in vivo, we used CRISPR/Cas9 to generate a germline mutant in zebrafish, but we do not find any evidence that bhlhe22 is required for formation of the p1 domain in zebrafish embryos. It is not clear why loss of bhlhe22 function produces different effects in zebrafish versus chick, but this may stem from the different approaches used – germline mutation in zebrafish versus transient siRNA-mediated knock-down in chick. The lack of a phenotype may also be the effect of compensatory mechanisms, either by other bHLH TFs - which are broadly expressed in the neural tube [72] – or by more general mechanisms operating to suppress the effects of genetic lesions [73]. We conclude that Prdm12b acts as a repressor of transcription – most likely by recruiting EHMT2/G9a – and that the Prdm12-mediated induction of genes such as p27 is most likely the result of indirect events.

An undefined domain persists at the p1 position in prdm12b mutants

The mechanism whereby prdm12 promotes formation of the p1 domain remains unclear. Mutual repression between TFs expressed in adjacent domains is the predominant mechanism for the creation of distinct domains along the dorsoventral axis of the vertebrate neural tube. Since prdm12 functions as a repressor, it is possible that it acts to repress the formation of adjacent domains. Indeed, overexpression and MO-based approaches in the frog have led to the suggestion that prdm12 and nkx6.1 (that is expressed in the p2, p3 and pMN domains) forms such a cross-repressive pair [23]. In this model, loss of prdm12 would lead to loss of eng1 expression due to nkx6.1 expression (and p2 fates) expanding into the p1 domain. However, our initial analyses of nkx6.1 mutant zebrafish do not support this model. First, if prdm12b is required for eng1 expression in the p1 domain due to its repression of nkx6.1, eng1b should be restored to the p1 domain in embryos lacking both nkx6.1 and prdm12b, but this is not what we observe. Second, if prdm12b and nkx6.1 cross-repress each other’s expression, prdm12b expression should expand ventrally in nkx6.1 mutants and vice versa, but this also does not occur. Lastly, when one member of a cross-repressive pair is mutated, the corresponding progenitor fate is usually replaced by the adjacent fate, but this is not the case in prdm12b mutants – where a domain persists at the p1 position, albeit in a narrower form. Since this domain does not express any of the genes diagnostic for various fates along the DV axis, its exact state is not clear. We note that prdm12 is reported to have anti-proliferative activity [49] and that p1 progenitor cells must exit the cell cycle prior to differentiating into V1 interneurons. It is therefore possible that prdm12 is required for this transition and that loss of prdm12 leaves cells in a proliferative progenitor state.

Conclusion

Our results demonstrate an essential role for prdm12b in zebrafish neurogenesis. By generating germline mutations, we show that a loss of function prdm12b allele results in lack of eng1b-expressing V1 interneurons, defective Mauthner cell-dependent locomotion – which is indistinguishable from prdm12b morphants – and ultimately embryonic lethality. Further analyses revealed that the Prdm12b zinc finger domain, which is essential for repression, is also necessary for binding to the Bhlhe22 TF, but not to EHMT2/G9a. We generated a bhlhe22 mutant zebrafish line, but find no evidence for bhlhe22 function in the formation of the p1 domain in zebrafish embryos. Lastly, upon examination of cross-repressive interaction between prdm12b and nkx6.1, we do not find evidence for nkx6.1 and prdm12b acting as a repressive pair in the formation of the p1/p2 boundary. Our results suggest that prdm12b does not only regulate eng1b expression in the p1 domain, but also takes part in regulating the size of this domain.

Abbreviations

bHLH: 

Basic Helix-Loop-Helix

CNS: 

Central nervous system

CRISPR: 

Clustered Regularly Interspaced Short Palindromic Repeats

DBD: 

DNA binding domain

dpf: 

Days post fertilization

DV: 

Dorsoventral

ENU: 

N-ethyl-N-nitrosourea

HD: 

Homeodomain

HDAC: 

Histone deacetylase

HMT: 

Histone methyl transferase

hpf: 

Hours post fertilization

MHB: 

Mid-hindbrain boundary

MO: 

Morpholino

sgRNA: 

Single guide RNA

Shh: 

Sonic hedgehog

TF: 

Transcription factor

TSA: 

Trichostatin A

WT: 

Wildtype

ZIRC: 

The Zebrafish International Resource Center

ZMP: 

Zebrafish Mutation Project

ZnF: 

Zinc Finger

Declarations

Acknowledgements

We are grateful to Dr. Scot Wolfe for advice regarding CRISPR/Cas9 mutagenesis. We acknowledge ZIRC for providing the prdm12bsa9887 mutant. The following monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242: Isl1/2 (39.4D5) antibody and HB9 (81.5C10) developed by T. M. Jessell and S. Brenner-Morton; 3A10 antibody developed by T. M. Jessell, J. Dodd, and S. Brenner-Morton; F310 antibody developed by F.E. Stockdale. This work was supported by NIH grant NS038183 to CGS and NSF grant IOS1456866 to GBD.

Funding

This work was supported by NIH grant NS038183 to CGS. The NIH had no role in the design of the study, in the collection, analysis, and interpretation of data or in writing the manuscript.

Availability of data and materials

Mutant lines generated in this study are available upon request.

Authors’ contributions

OY participated in the design of the study, generated the CRISPR-based mutant lines, performed all in situ and immunochemistry analysis of the mutant lines, carried out all reporter assays and co-immunoprecipitation experiments, performed the computational analyses of escape responses and drafted the manuscript. GBD carried out and recorded the escape response, assisted in data interpretation, reviewed, edited and approved the manuscript. CGS conceived the study, secured funding, participated in study design, and finalized the manuscript. All authors read and approved the final manuscript.

Ethics approval

This study was submitted to and approved by the University of Massachusetts Medical School Institutional Animal Care and Use Committee and the University of Massachusetts Medical School Institutional Review Board.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, 364 Plantation St/LRB815, Worcester, MA 01605, USA
(2)
Department of Biology, University of Massachusetts, Amherst, MA 01003, USA

References

  1. Del Pino I, Rico B, Marín O. Neural circuit dysfunction in mouse models of neurodevelopmental disorders. Curr Opin Neurobiol. 2018;48:174–82.View ArticleGoogle Scholar
  2. Jessell TM, Sanes JR. Development. The decade of the developing brain. Curr. Opin. Neurobiol. 2000;10:599–611.View ArticleGoogle Scholar
  3. Lee KJ, Jessell TM. The specification of dorsal cell fates in the vertebrate central nervous system. Annu. Rev. Neurosci. Annual Reviews 4139 El Camino Way, P.O. Box 10139, Palo Alto, CA 94303–0139, USA; 1999;22:261–94.Google Scholar
  4. Wilson L, Maden M. The mechanisms of dorsoventral patterning in the vertebrate neural tube. Dev Biol. 2005;282:1–13.View ArticleGoogle Scholar
  5. Briscoe J, Pierani A, Jessell TM, Ericson J. A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube. Cell. 2000;101:435–45.View ArticleGoogle Scholar
  6. Ericson J, Rashbass P, Schedl A, Brenner-Morton S, Kawakami A, van Heyningen V, et al. Pax6 controls progenitor cell identity and neuronal fate in response to graded Shh signaling. Cell. 1997;90:169–80.View ArticleGoogle Scholar
  7. Pierani A, Brenner-Morton S, Chiang C, Jessell TM. A sonic hedgehog-independent, retinoid-activated pathway of neurogenesis in the ventral spinal cord. Cell. 1999;97:903–15.View ArticleGoogle Scholar
  8. Novitch BG, Chen AI, Jessell TM. Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2. Neuron. 2001;31:773–89.View ArticleGoogle Scholar
  9. Vallstedt A, Muhr J, Pattyn A, Pierani A, Mendelsohn M, Sander M, et al. Different levels of repressor activity assign redundant and specific roles to Nkx6 genes in motor neuron and interneuron specification. Neuron. 2001;31:743–55.View ArticleGoogle Scholar
  10. Briscoe J, Sussel L, Serup P, Hartigan-O'Connor D, Jessell TM, Rubenstein JL, et al. Homeobox gene Nkx2.2 and specification of neuronal identity by graded sonic hedgehog signalling. Nature. Nat Publ Group. 1999;398:622–7.Google Scholar
  11. Pabst O, Herbrand H, Takuma N, Arnold HH. NKX2 gene expression in neuroectoderm but not in mesendodermally derived structures depends on sonic hedgehog in mouse embryos. Dev Genes Evol. 2000;210:47–50.View ArticleGoogle Scholar
  12. Chiang C, Litingtung Y, Lee E, Young KE, Corden JL, Westphal H, et al. Cyclopia and defective axial patterning in mice lacking sonic hedgehog gene function. Nature. Nature Publishing Group; 1996;383:407–413.Google Scholar
  13. Qiu M, Shimamura K, Sussel L, Chen S, Rubenstein JL. Control of anteroposterior and dorsoventral domains of Nkx-6.1 gene expression relative to other Nkx genes during vertebrate CNS development. Mech Dev. 1998;72:77–88.View ArticleGoogle Scholar
  14. Zhou Q, Anderson DJ. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell. 2002;109:61–73.View ArticleGoogle Scholar
  15. Zannino DA, Sagerström CG. An emerging role for prdm family genes in dorsoventral patterning of the vertebrate nervous system. Neural Dev [Internet]. 2015;10:24. Available from: http://www.neuraldevelopment.com/content/10/1/24
  16. Hohenauer T, Moore AW. The Prdm family: expanding roles in stem cells and development. Development [internet]. 2012;139:2267–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22669819.
  17. Fog CK, Galli GG, Lund AH. PRDM proteins: important players in differentiation and disease. Bioessays [internet]. 2012;34:50–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22028065.
  18. Chang JC, Meredith DM, Mayer PR, Borromeo MD, Lai HC, Ou Y-H, et al. Prdm13 mediates the balance of inhibitory and excitatory neurons in somatosensory circuits. Dev Cell. 2013;25:182–95 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3644180.View ArticleGoogle Scholar
  19. Hanotel J, Bessodes N, Thélie A, Hedderich M, Parain K, Van Driessche B, et al. The Prdm13 histone methyltransferase encoding gene is a Ptf1a-Rbpj downstream target that suppresses glutamatergic and promotes GABAergic neuronal fate in the dorsal neural tube. Dev Biol. 2014;386:340–57 Available from: http://linkinghub.elsevier.com/retrieve/pii/S0012160613006817.View ArticleGoogle Scholar
  20. Ross SE, McCord AE, Jung C, Atan D, Mok SI, Hemberg M, et al. Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly. Neuron. 2012;73:292–303 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3269007.View ArticleGoogle Scholar
  21. Kinameri E, Inoue T, Aruga J, Imayoshi I, Kageyama R, Shimogori T, et al. Prdm proto-oncogene transcription factor family expression and interaction with the Notch-Hes pathway in mouse neurogenesis. Hendricks M, editor. PLoS ONE [Internet]. 2008;3:e3859. Available from: http://dx.plos.org/10.1371/journal.pone.0003859
  22. Zannino DA, Downes GB, Sagerström CG. prdm12b specifies the p1 progenitor domain and reveals a role for V1 interneurons in swim movements. Developmental Biology [Internet]. 2014;390:247–60. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4030435
  23. Thelie A, Thélie A, Desiderio S, Desiderio S, Hanotel J, Hanotel J, et al. Prdm12 specifies V1 interneurons through cross-repressive interactions with Dbx1 and Nkx6 genes in Xenopus. Development. 2015;142:3416–28 Available from: http://dev.biologists.org/cgi/doi/10.1242/dev.121871.View ArticleGoogle Scholar
  24. Matsukawa S, Miwata K, Asashima M, Michiue T. The requirement of histone modification by PRDM12 and Kdm4a for the development of pre-placodal ectoderm and neural crest in Xenopus. Dev Biol. 2015;399:164–76 Available from: http://linkinghub.elsevier.com/retrieve/pii/S0012160614006691.View ArticleGoogle Scholar
  25. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Dev Dyn. 1995;203:253–310.View ArticleGoogle Scholar
  26. Montague TG, Cruz JM, Gagnon JA, Church GM, Valen E. CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res. 2014;42:W401–7.View ArticleGoogle Scholar
  27. Maurer JM, Sagerström CG. A parental requirement for dual-specificity phosphatase 6 in zebrafish. BMC Dev Biol. 2018;18:6.View ArticleGoogle Scholar
  28. Gagnon JA, Valen E, Thyme SB, Huang P, Akhmetova L, Ahkmetova L, et al. Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs. Riley B, editor. PLoS ONE. 2014;9:e98186.Google Scholar
  29. Hauptmann G, Gerster T. Multicolor whole-mount in situ hybridization. In: Methods Mol Biol, vol. 137. New Jersey: Humana Press; 2000. p. 139–48.Google Scholar
  30. Zannino DA, Appel B. Olig2+ precursors produce abducens motor neurons and oligodendrocytes in the zebrafish hindbrain. J Neurosci Society for Neuroscience. 2009;29:2322–33.View ArticleGoogle Scholar
  31. Ladam F, Stanney W, Donaldson IJ, Yildiz O, Bobola N, Sagerström CG. TALE factors use two distinct functional modes to control an essential zebrafish gene expression program. eLife. eLife Sciences Publications Limited; 2018;7:28.Google Scholar
  32. Hatta K. Role of the floor plate in axonal patterning in the zebrafish CNS. Neuron. 1992;9:629–42.View ArticleGoogle Scholar
  33. Kok FO, Oster E, Mentzer L, Hsieh J-C, Henry CA, Sirotkin HI. The role of the SPT6 chromatin remodeling factor in zebrafish embryogenesis. Dev Biol. 2007;307:214–26.View ArticleGoogle Scholar
  34. Ericson J, Thor S, Edlund T, Jessell TM, Yamada T. Early stages of motor neuron differentiation revealed by expression of homeobox gene Islet-1. Science. 1992;256:1555–60.View ArticleGoogle Scholar
  35. Tanabe Y, William C, Jessell TM. Specification of motor neuron identity by the MNR2 homeodomain protein. Cell. 1998;95:67–80.View ArticleGoogle Scholar
  36. Zannino DA, Sagerström CG, Appel B. olig2-Expressing hindbrain cells are required for migrating facial motor neurons. Dev. Dyn. Wiley-Liss, Inc; 2012;241:315–26.Google Scholar
  37. McKeown KA, Moreno R, Hall VL, Ribera AB, Downes GB. Disruption of Eaat2b, a glutamate transporter, results in abnormal motor behaviors in developing zebrafish. Dev Biol. 2012;362:162–71.View ArticleGoogle Scholar
  38. Higashijima S-I, Higashijima SI, Masino MA, Mandel G, Fetcho JR. Engrailed-1 expression marks a primitive class of inhibitory spinal interneuron. J Neurosci. 2004;24:5827–39 Available from: http://www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.5342-03.2004.View ArticleGoogle Scholar
  39. Alvarez FJ, Jonas PC, Sapir T, Hartley R, Berrocal MC, Geiman EJ, et al. Postnatal phenotype and localization of spinal cord V1 derived interneurons. J. Comp. Neurol. Wiley subscription services, Inc., A Wiley Company; 2005;493:177–92.Google Scholar
  40. Gosgnach S, Lanuza GM, Butt SJB, Saueressig H, Zhang Y, Velasquez T, et al. V1 spinal neurons regulate the speed of vertebrate locomotor outputs. Nature. 2006;440:215–9 Available from: http://www.ncbi.nlm.nih.gov/pubmed/16525473.View ArticleGoogle Scholar
  41. Lawson ND, Wolfe SA. Forward and reverse genetic approaches for the analysis of vertebrate development in the zebrafish. Dev Cell. 2011;21:48–64.View ArticleGoogle Scholar
  42. Stainier DYR, Kontarakis Z, Rossi A. Making sense of anti-sense data. Dev Cell. 2015;32:7–8.View ArticleGoogle Scholar
  43. Shalem O, Sanjana NE, Zhang F. High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet Nature Research. 2015;16:299–311.View ArticleGoogle Scholar
  44. Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. American Association for the Advancement of Science; 2014;346:1258096–6.Google Scholar
  45. Goulding M. Circuits controlling vertebrate locomotion: moving in a new direction. Nat Rev Neurosci. 2009;10:507–18 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2847453.View ArticleGoogle Scholar
  46. Eaton RC, Lee RK, Foreman MB. The Mauthner cell and other identified neurons of the brainstem escape network of fish. Prog Neurobiol. 2001;63:467–85.View ArticleGoogle Scholar
  47. Jain RA, Bell H, Lim A, Chien C-B, Granato M. Mirror movement-like defects in startle behavior of zebrafish dcc mutants are caused by aberrant midline guidance of identified descending hindbrain neurons. J Neurosci. 2014;34:2898–909.View ArticleGoogle Scholar
  48. Liu KS, Fetcho JR. Laser ablations reveal functional relationships of segmental hindbrain neurons in zebrafish. Neuron. 1999;23:325–35.View ArticleGoogle Scholar
  49. Yang C-M, Shinkai Y. Prdm12 is induced by retinoic acid and exhibits anti-proliferative properties through the cell cycle modulation of P19 embryonic carcinoma cells. Cell Struct. Funct. 2013;38:197–206 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23856557.View ArticleGoogle Scholar
  50. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M, et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 2000;406:593–9.View ArticleGoogle Scholar
  51. Eom GH, Kim K, Kim S-M, Kee HJ, Kim J-Y, Jin HM, et al. Histone methyltransferase PRDM8 regulates mouse testis steroidogenesis. Biochemical and Biophysical Research Communications [Internet] 2009;388:131–6. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0006291X09015058
  52. Hayashi K, Yoshida K, Matsui Y. A histone H3 methyltransferase controls epigenetic events required for meiotic prophase. Nature. Nature Publishing Group. 2005;438:374–8.Google Scholar
  53. Derunes C, Briknarová K, Geng L, Li S, Gessner CR, Hewitt K, et al. Characterization of the PR domain of RIZ1 histone methyltransferase. Biochemical and biophysical research communications [internet]. 2005;333:925–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15964548.
  54. Wu Y, Ferguson JE, Wang H, Kelley R, Ren R, McDonough H, et al. PRDM6 is enriched in vascular precursors during development and inhibits endothelial cell proliferation, survival, and differentiation. J Mol Cell Cardiol. 2008;44:47–58 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2683064.View ArticleGoogle Scholar
  55. Pinheiro I, Margueron R, Shukeir N, Eisold M, Fritzsch C, Richter FM, et al. Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. Cell. 2012;150:948–60.View ArticleGoogle Scholar
  56. Koh-Stenta X, Joy J, Poulsen A, Li R, Tan Y, Shim Y, et al. Characterization of the histone methyltransferase PRDM9 using biochemical, biophysical and chemical biology techniques. Biochem J. 2014;461:323–34 Available from: http://biochemj.org/lookup/doi/10.1042/BJ20140374.View ArticleGoogle Scholar
  57. Yu J, Angelin-Duclos C, Greenwood J, Liao J, Calame K. Transcriptional repression by Blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol. 2000;20:2592–603.View ArticleGoogle Scholar
  58. Chittka A, Arevalo JC, Rodriguez-Guzman M, Pérez P, Chao MV, Sendtner M. The p75NTR-interacting protein SC1 inhibits cell cycle progression by transcriptional repression of cyclin E. J Cell Biol Rockefeller University Press; 2004;164:985–96.Google Scholar
  59. Davis CA, Davis CA, Haberland M, Haberland M, Arnold MA, Arnold MA, et al. PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. Mol Cell Biol. 2006;26:2626–36 Available from: http://mcb.asm.org/cgi/doi/10.1128/MCB.26.7.2626-2636.2006.View ArticleGoogle Scholar
  60. Skaggs K, Martin DM, Novitch BG. Regulation of spinal interneuron development by the Olig-related protein Bhlhb5 and notch signaling. Development. 2011;138:3199–211.View ArticleGoogle Scholar
  61. Ren B, Chee KJ, Kim TH, Maniatis T. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes dev. Cold Spring Harbor Laboratory Press; 1999;13:125–37.Google Scholar
  62. Kajimura S, Seale P, Tomaru T, Erdjument-Bromage H, Cooper MP, Ruas JL, et al. Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev. 2008;22:1397–409.View ArticleGoogle Scholar
  63. Nishikata I, Nakahata S, Saito Y, Kaneda K, Ichihara E, Yamakawa N, et al. Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation. Oncogene Nature Publishing Group; 2011;30:4194–207.Google Scholar
  64. Palmer S, Brouillet JP, Kilbey A, Fulton R, Walker M, Crossley M, et al. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. J Biol Chem. 2001;276:25834–40.View ArticleGoogle Scholar
  65. Győry I, Wu J, Fejér G, Seto E, Wright KL. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nature Immunology Nature Publishing Group; 2004;5:299–308.Google Scholar
  66. Duan Z, Person RE, Lee H-H, Huang S, Donadieu J, Badolato R, et al. Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5. Mol Cell Biol. 2007;27:6889–902.View ArticleGoogle Scholar
  67. Sander M, Paydar S, Ericson J, Briscoe J, Berber E, German M, et al. Ventral neural patterning by Nkx homeobox genes: Nkx6.1 controls somatic motor neuron and ventral interneuron fates. Genes dev. Cold Spring Harbor Laboratory Press; 2000;14:2134–9.Google Scholar
  68. Hutchinson SA, Cheesman SE, Hale LA, Boone JQ, Eisen JS. Nkx6 proteins specify one zebrafish primary motoneuron subtype by regulating late islet1 expression. Development. The Company of Biologists Ltd; 2007;134:1671–7.Google Scholar
  69. Cheesman SE, Layden MJ, Ohlen Von T, Doe CQ, Eisen JS. Zebrafish and fly Nkx6 proteins have similar CNS expression patterns and regulate motoneuron formation. Development The Company of Biologists Ltd; 2004;131:5221–32.Google Scholar
  70. Stainier DY, Fouquet B, Chen JN, Warren KS, Weinstein BM, Meiler SE, et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development. 1996;123:285–92.PubMedGoogle Scholar
  71. Weicksel SE, Gupta A, Zannino DA, Wolfe SA, Sagerström CG. Targeted germ line disruptions reveal general and species-specific roles for paralog group 1 hox genes in zebrafish. BMC Dev. Biol. 2014;14:25.View ArticleGoogle Scholar
  72. Bertrand N, Castro DS, Guillemot F. Proneural genes and the specification of neural cell types. Nat Rev Neurosci Nature Publishing Group; 2002;3:517–30.Google Scholar
  73. Rossi A, Kontarakis Z, Gerri C, Nolte H, Hölper S, Krüger M, et al. Genetic compensation induced by deleterious mutations but not gene knockdowns. Nature Nature Publishing Group; 2015;524:230–3.Google Scholar

Copyright

© The Author(s). 2019

Advertisement

Neural Development

ISSN: 1749-8104